Depression and anxiety levels in therapy-naïve patients with inflammatory bowel disease and cancer of the colon

Table 2 Expression of the anxiousness symptoms according to the Hamilton’s Anxiety Rating Inventory (IBD/CCa)

Symptom	0	1	2	3	4	Statistical analysis
Anxious mood-greed, hopelessness	4/9	1/8	6/5	10/5	11/3	χ2 = 13.55, DF = 4, P = 0.009
Tension	4/7	1/8	6/5	10/9	11/1	χ2 = 14.69, DF = 4, P = 0.005
Fears: dark, loneliness, animals	19/26	2/1	4/2	7/0	0/1	χ2 = 10.03, DF = 4, P = 0.04
Intellectual impairments-memory problems, difficulties in communication	18/22	6/4	5/4	3/0	-	χ2 = 3.85, DF = 3, P > 0.05
Depressive aspect	5/15	3/4	4/8	6/1	2/14	χ2 = 19.003, DF = 4, P = 0.002
Somatic symptoms: muscular symptoms, sensory symptoms-tinnitus, blurred vision, attacks of heath, itching, etc., cardiovascular symptoms-tachycardia, palpitations, sense of pulsing, irregularities in heart actions, respiratory symptoms, urogenital symptoms	16/9	3/3	7/10	2/7	4/1	χ2 = 7.01, DF = 4, P > 0.05
Neurovegetative symptoms-face blushing, mouth dryness, vertigo, sweating	20/18	1/6	7/6	4/0	-	χ2 = 7.7, DF = 4, P > 0.05
Behavior during the interview-restlessness, agitation, walking around, frowned face, tense, sobbing, accelerated breathing, pallor, gulping and belching, vivid muscular reflexes, jerks, dilated pupillae, exophthalmus	4/10	0/5	8/13	10/0	10/0	χ2 = 24.06, DF = 4, P < 0.001
Mean score ± SD	16.22 ± 7.42/9.73 ± 6.03; t = 3.76, DF = 60, P < 0.01